» Articles » PMID: 32039351

Acute-on-chronic Liver Failure: Objective Admission and Support Criteria in the Intensive Care Unit

Overview
Journal JHEP Rep
Specialty Gastroenterology
Date 2020 Feb 11
PMID 32039351
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Cirrhosis is a leading cause of morbidity and mortality throughout the world. Significant complications include variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, and infection. When these complications are severe, admission to the intensive care unit (ICU) is often required for organ support and management. Intensive care therapy can also serve as a bridge to liver transplantation. Along with decompensation of cirrhosis, the concept of acute-on-chronic liver failure (ACLF) has emerged. This involves an acute precipitating event, such as the development of infection in a patient with cirrhosis, which leads to acute deterioration of hepatic function and extrahepatic organ failure. Extrahepatic complications often include renal, cardiovascular, and respiratory failures. Patients with significant extrahepatic and hepatic failures need ICU admission for organ support. Again, in patients who are deemed suitable liver transplant candidates, intensive care management may allow bridging to liver transplantation. However, patients with a Chronic Liver Failure Consortium ACLF score greater than 70 at 48 to 72 hours post-ICU admission do not seem to benefit from ongoing intensive support and a palliative approach may be more appropriate.

Citing Articles

Serum Adiponectin Is Elevated in Critically Ill Patients with Liver Disease and Associated with Decreased Overall Survival.

Pollmanns M, Pajaziti Q, Hohlstein P, Adams J, Abu Jhaisha S, Kabak E Biomedicines. 2024; 12(10).

PMID: 39457486 PMC: 11504267. DOI: 10.3390/biomedicines12102173.


Barriers and Strategies to Effective Serious Illness Communication for Patients with End-Stage Liver Disease in the Intensive Care Setting.

Brown C, Khan S, Parekh T, Muir A, Sudore R J Intensive Care Med. 2024; :8850666241280892.

PMID: 39247992 PMC: 11890205. DOI: 10.1177/08850666241280892.


Intensive care unit admission criteria: a scoping review.

Soares J, Leung C, Campbell V, Van Der Vegt A, Malycha J, Andersen C J Intensive Care Soc. 2024; 25(3):296-307.

PMID: 39224425 PMC: 11366187. DOI: 10.1177/17511437241246901.


[When should a liver disease patient be admitted to the intensive care unit?].

Kaya E, Nekarda P, Traut I, Aurich P, Canbay A, Katsounas A Med Klin Intensivmed Notfmed. 2024; 119(6):470-477.

PMID: 39017943 DOI: 10.1007/s00063-024-01160-w.


Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit.

Zhu Z, Huang X, Jiang H, Liu L World J Gastroenterol. 2024; 30(20):2657-2676.

PMID: 38855159 PMC: 11154676. DOI: 10.3748/wjg.v30.i20.2657.


References
1.
Moreau R, Hadengue A, Soupison T, Kirstetter P, Mamzer M, Vanjak D . Septic shock in patients with cirrhosis: hemodynamic and metabolic characteristics and intensive care unit outcome. Crit Care Med. 1992; 20(6):746-50. DOI: 10.1097/00003246-199206000-00008. View

2.
Olson J, Saeian K . Gastrointestinal Issues in Liver Disease. Crit Care Clin. 2016; 32(3):371-84. DOI: 10.1016/j.ccc.2016.03.007. View

3.
Arora V, Maiwall R, Rajan V, Jindal A, Shasthry S, Kumar G . Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure. Hepatology. 2018; 71(2):600-610. DOI: 10.1002/hep.30208. View

4.
Levy M, Evans L, Rhodes A . The Surviving Sepsis Campaign Bundle: 2018 update. Intensive Care Med. 2018; 44(6):925-928. DOI: 10.1007/s00134-018-5085-0. View

5.
Merli M, Lucidi C, Giannelli V, Giusto M, Riggio O, Falcone M . Cirrhotic patients are at risk for health care-associated bacterial infections. Clin Gastroenterol Hepatol. 2010; 8(11):979-85. DOI: 10.1016/j.cgh.2010.06.024. View